Reading time is 3 mins
.
.
THE NEWS THAT THE WORLD HAS BEEN WAITING FOR WITH HOPE HAS ARRIVED: THE MYSTERY OF OMICRON HAS BEEN SOLVED!
Recently, scientists have reached a very important information about the Omicron variant, which has not fallen off the agenda. One of the biggest mysteries in the new variant has been deciphered. Experts commented that in this way, the way to determine the treatment methods that will better combat Omicron has been paved. (Freedom)
The world has been in the grip of the coronavirus (COVID-19) for two years, so to speak… The virus, which has cost the lives of close to 5.5 million people worldwide, has caused us to leave our old normal behind.
The virus, which is transmitted to more than a quarter of a billion people, has recently been on the agenda with its variants. The last variant that alarmed the world is Omicron, which appeared in South Africa.
.
AND THE MYSTERY IS SOLVED
As the research on the new variant, which soon became the number one common agenda in the world, continues at full speed, scientists have announced that they have solved one of the biggest mysteries in the variant.
Omicron, which is rapidly replacing the Delta variant, is expected to become the dominant type worldwide in the coming weeks. Because Omicron is faster than predicted.
.
RESULTS THAT DISRUPT MEMORIZATION
But the first information that has come is promising. Compared to Omicron Delta, it causes milder symptoms and disease. Here the reason for this was finally determined.
.
70 TIMES FASTER
Comparing it to Omicron and Delta, scientists have determined that Omicron multiplies in the airways 70 times faster than Delta. A study conducted at the University of Hong Kong found that the new variant reproduces 10 times slower in the lungs compared to Delta.
Scientists studying how quickly the new variant multiplies in the bronchial and lung tissue believe that these results explain why Omicron causes a very contagious, but milder disease.
.
PAY ATTENTION TO THESE SYMPTOMS IN OMICRON
It is noted that the symptoms of Omicron are also different from Delta. For example, while there is no loss of taste and smell in patients, symptoms that have not been encountered before appear.
According to the British Mirror newspaper titled ‘Five new symptoms of Omicron and the difference of the new variant from the original virus’, the 5 symptoms to watch out for in the new variant are as follows…
In contrast to sore throat, a feeling of itching in the throat dry cough Excessive fatigue Mild muscle aches Night sweats
.
WHAT IS THE MOST EFFECTIVE VACCINE?
With the help of a study of the United Kingdom Health and Safety Agency (UKHSA), which concluded that two doses of the vaccine may be ineffective against the Omicron variant. he determined the vaccine that provides the most protection after the dose.
According to the first analysis by UKHSA, two doses of Pfizer provide only 30 to 40 percent protection against a symptomatic infection caused by Omicron. According to the same analysis, this ratio is 3. the dose increases to 75 after Pfizer.
According to the UKHSA, if you received an Astrazeneca vaccine six months ago, the effectiveness of the vaccine against a symptomatic Omicron infection is close to zero. If your first two vaccines are Astrazeneca, the effectiveness reaches 70 percent if you have a Pfizer booster vaccine.
In the light of these data, it seems that the Pfizer vaccine, which is also used in our country, offers better protection than the British Astrazeneca. These results for the Moderna and J&J vaccines are expected to be announced in the coming days.
.
HERE IS THE MOST AFFECTED AGE GROUP
The Advisory Committee of the South African Ministry of Health, says that, as in previous waves, young people got sick first on Omicron.
The doctor’s experience so far has been that the variant affects people who are 40 or younger. South African health minister Doctor noted that young people are the most affected by Omicron, as vaccination rates are relatively low.
.
.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.